Human Retinal Imaging Biomarkers for FTLD-Tau in Relation to FTLD-TDP and Nonamnestic AD
Description: Project Narrative The proposed research is relevant to public health because the development of retinal imaging as a biomarker for frontotemporal degeneration (FTD) pathology will enable proper enrollment of these patients into clinical trials testing mechanism-based therapies, thereby greatly improving the chance to find a treatment for these patients. Thus, the proposed research is relevant to the NIH’s mission to enable discoveries that will improve human health.
Funder: National Institute on Aging
Funding type: research
Funder scheme: RF1
Start date: 2023-09-01
End date: 2026-08-31
Investigator: BENJAMIN J. KIM
Institution: UNIVERSITY OF PENNSYLVANIA
Funded outputs count: 6
Funder award ID: RF1AG083774
OpenAlex ID: G4213498687